SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-050905
Filing Date
2013-06-24
Accepted
2013-06-24 08:30:19
Documents
5
Period of Report
2013-06-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-15366_18k.htm 8-K 25021
2 EX-99.1 a13-15366_1ex99d1.htm EX-99.1 75127
3 GRAPHIC g153661mmi001.jpg GRAPHIC 2799
4 GRAPHIC g153661mmi002.jpg GRAPHIC 20966
5 GRAPHIC g153661mmi003.jpg GRAPHIC 2456
  Complete submission text file 0001104659-13-050905.txt   137876
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 13928478
SIC: 2834 Pharmaceutical Preparations